← Back to headlines
US FDA warns Novo again about misleading drug advertising - Reuters
US FDA warns Novo Nordisk again about misleading advertising for its diabetes drug Ozempic, according to a letter from the agency seen by Reuters.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
55m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
8h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
11h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago